metabolic disorders and screening Flashcards

1
Q

causes of defect in enzyme activity

A
  • lack of enzyme
  • reduced enzyme activity due to:
    1. defects of post-translational modification,
    2. assembly
    3. transportation
  • defects of cofactor activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

general effect of deficiency of enzyme activity

A

lack of end product
build up of precursers
abnormal, toxic, metabolites
* Km – how high concentration of substrate has to be, before enzyme interested.
* If get high conc of substrates can get enzyme interested -> toxic metabolies
* These factors are biological hallmarks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

criteria to screen for a metabolic disease

A
  • Important health problem
  • Accepted treatment
  • Facilities for diagnosis and treatment
  • Latent or early symptomatic stage - no point screening if early sx
  • Suitable test or examination
  • Test should be acceptable to the population
  • Natural history understood
  • Agreed policy on whom to treat as patients
  • Economically balanced
  • Continuing process - update what screen for
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pathway involved in phenylketonuria

A

Phenylalanine is essential amino acid – normally metabolised through tyrosine

If phenylalanine hydroxylase is deficient -> build up of phenylalanine = toxic

Also get phenylpyruvate and phenylacetic acid – abnormal metabolites of phenylalanine

Phenylacetic acid seen in urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

problem with phenylketonuria (PKU)

A

phenylalanine is toxic to CNS - low IQ less than 50

no physical sx

it is common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

dx and mx of phenylketonuria

A

Test is to measure blood phenylalanine
Cant do genetic test – too many mutations

Cant get rid of phenylalanine – it is an essential amino acid, so need some.

Treatment has to be started within 1st 6wks of life - expensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sensitivity =

A

true +ve / total disease present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

specificity =

A

true -ve / total disease absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

positive predictive value =

A

true +ve / +ve test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

negative predictive value =

A

true -ve / total -ve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

is sensitivity or specificity more important in screening

A

sensitivity - unethical to miss cases - better to have false +ves

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how do we screen for inherited metabolic disorders

A

guthrie test on day 5-8

heal prick form posterior medial 1/3 of foot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the positive predictive value for PKU guthrie test

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how is congenital hypothyroidism screened for and what is the usual cause

A

guthrie - look for gigh TSH
PPV = 60-70%

usually dysgenesis/agenesis of thyroid gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

features of congenital hypothyroidism

A
  • large tongue,
  • mottling of face,
  • umbilical hernia,
  • hoarse cry.
  • High TSH.

Treatable with thyroxine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

pathology of CF

A

6 classes of defect.
Failure of Cl- ion movement from inside epithelial cell into lumen
-> increased reabsorption of Na+ /H2O
-> viscous secretions
-> ductule blockage

17
Q

features of CF

A

Lungs – recurrent infection
Pancreas –malabsorption, steatorrhoea, diabetes
Liver – cirrhosis

18
Q

blood in CF in a neonate

A

high blood immune reactive trypsin

19
Q

screening for CF

A
20
Q

how does mass spectrometry work

A

Ionise molecule
Then fragment it in a controlled way
Bits of molecules can separate on mass and charge

Unique footprint to molecule
If further fragement twice -> tandem mass spec

Can pick up a lot of abnormal metabolites

21
Q

what is screened for in the UK

A

PKU from 1969
Congenital hypothyroidism added 1970
Sickle cell disease added 2006
Cystic fibrosis added 2007

Medium chain AcylCoA dehydrogenase (MCADD) added 2009

22
Q

how is mitochondrial fatty acid B-oxidation screened for (MCADD)

A

acylcarnitine levels by tandem MS

23
Q

MCADD pathway

A

Break down fatty acids in mitochondiroa
If MCAD missing – don’t produce acetyl CoA – used for TCA cycle or for producing ketones – both spare glucose.

Use fat when fasting, to spare glucose.

24
Q

consequence of MCADD

A

cot death - cant break down fat

25
Q

Rx of MCADD

A

make sure never become hypoglycaemic – don’t depend on fat.

Feed them over night with cornstarch

26
Q

what is homocystinuria

A

failure of methylation of homocysteine - causes:
* lens dislocation,
* mental retardation
* thromboembolism at early age.

wales screen for this